Skip to content

Pondering the Twitter practices of pharmaceutical companies

In the context of pharmaceutical companies, Steve Woodruff discusses the tradeoffs of a personalized Twitter feed versus a homogenized feed on KevinMD:

As more and more pharmaceutical companies dip their toes into social media, one of the issues that surfaces regularly is this: do you put someONE in charge of a blog and/or Twitter account, or do you make it more anonymous? Or something else?

Popular posts

Biomedical research
How do the new COVID-19 vaccines work?

The Pfizer and Moderna COVID-19 vaccines are the first to use the RNA coding molecule to prompt our bodies to fight the virus. Here's how they work.